Top Markets
#1 EXOD EXOD +22.08%
#2 XPIN Network XPIN Network +20.61%
#3 Geodnet Geodnet +17.47%
#4 BOOK OF MEME BOOK OF MEME +17.24%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +16.30%
#6 Bitcoin Cash Bitcoin Cash +15.99%
#7 SSV Network SSV Network +15.42%
#8 Derive Derive +15.10%
#9 The Black Bull The Black Bull +14.65%
#10 Mubarak Mubarak +14.16%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Rangering i aksjer #25246
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Aksjekurs
$23.57
Sist synkronisert: 2026-08-20
Markedsverdi
$51.76M
Endring (1 dag)
-0.08%
Endring (1 år)
289.59%
Land
US
Handel Apollomics, Inc. (APLM)

Kategori

Healthcare
Inntekter for Apollomics, Inc. (APLM)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Apollomics, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Apollomics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US